Keywords: world, thrombotics, market, forecasts, worldwide, thromboembolic, disease
World thrombotics market forecasts
Article | 03 May 2000
The worldwide thromboembolic disease therapeutics market, consisting ofanticoagulants, antiplatelets and thrombolytics, is expected to reach a value of $10.9 billion by 2005, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
